The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AFFIMED NV | COM | N01045108 | 2,221 | 714,079 | SH | SOLE | 714,079 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 4,702 | 6,547,774 | SH | SOLE | 6,547,774 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 14,971 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 7,540 | 2,185,426 | SH | SOLE | 2,185,426 | 0 | 0 | ||
| ALPHATEC HOLDINGS INC | COM NEW | 02081G201 | 775 | 338,278 | SH | SOLE | 338,278 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 14,733 | 3,981,867 | SH | SOLE | 3,981,867 | 0 | 0 | ||
| BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 13,174 | 217,395 | SH | SOLE | 217,395 | 0 | 0 | ||
| CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 182 | 41,688 | SH | SOLE | 41,688 | 0 | 0 | ||
| CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 832 | 147,011 | SH | SOLE | 147,011 | 0 | 0 | ||
| CORREVIO PHARMA CORP | COM | 22026V105 | 1,056 | 424,101 | SH | SOLE | 424,101 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 7,920 | 1,313,429 | SH | SOLE | 1,313,429 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM NEW | 12648L601 | 4,201 | 5,726,579 | SH | SOLE | 5,726,579 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 4,643 | 1,293,177 | SH | SOLE | 1,293,177 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 6,797 | 2,675,889 | SH | SOLE | 2,675,889 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 463 | 114,710 | SH | SOLE | 114,710 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 6,947 | 4,210,153 | SH | SOLE | 4,210,153 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 447 | 531,662 | SH | SOLE | 531,662 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 4,887 | 4,072,301 | SH | SOLE | 4,072,301 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 5,173 | 357,960 | SH | SOLE | 357,960 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 2,841 | 222,321 | SH | SOLE | 222,321 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 3,589 | 3,418,402 | SH | SOLE | 3,418,402 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 5,771 | 220,848 | SH | SOLE | 220,848 | 0 | 0 | ||